Find policies, billing codes, payers, states, and providers

HCPCS P9012: Cryoprecipitate, Each Unit

HCPCS Level II code P9012 designates a single unit of cryoprecipitate, a plasma-derived blood product rich in fibrinogen and clotting factors. Cryoprecipitate is an essential therapy for bleeding or coagulopathy related to low fibrinogen, certain inherited bleeding disorders, and during massive transfusion protocols. Nationally, accurate coding for cryoprecipitate affects hospital transfusion management, inventory tracking, and payer reimbursement for blood products.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for P9012, typical sites of service where the product is used, and the payers most commonly involved in coverage and claims adjudication. The publication summarizes billing benchmarks, common modifier usage patterns where available, and relevant policy considerations affecting coverage and billing for cryoprecipitate.

This summary is intended to inform billing professionals, hospital revenue cycle teams, and clinicians involved in transfusion services about the role of HCPCS Level II code P9012, common operational settings, and the payer landscape without providing clinical guidance or prescriptive recommendations.

Customize your policy alerts

Sign up for hcpcs P9012 policy alerts

Get alerted when payer policies referencing P9012 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

HCPCS Level II code P9012 represents cryoprecipitate, each unit. This item is a blood product derived from plasma that contains concentrated clotting factors, typically used to treat patients with hypofibrinogenemia, von Willebrand disease, or other coagulopathies.

Service type: Blood product transfusion supply
Typical site of service: Hospital inpatient, hospital outpatient, ambulatory surgical center, and transfusion centers where blood products are administered

Find policies, billing codes, payers, states, and providers

HCPCS P9012: Cryoprecipitate, Each Unit

Customize your policy alerts

Sign up for hcpcs P9012 policy alerts

Get alerted when payer policies referencing P9012 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

Service type: Blood product transfusion supply
Typical site of service: Hospital inpatient, hospital outpatient, ambulatory surgical center, and transfusion centers where blood products are administered

Clinical & Coding Specifications

Clinical Context

A typical patient scenario involves an adult inpatient with active bleeding or at high risk for bleeding due to hypofibrinogenemia, disseminated intravascular coagulation (DIC), massive transfusion, or congenital fibrinogen deficiency who requires transfusion support. Cryoprecipitate (P9012, cryoprecipitate, each unit) is prepared by thawing frozen plasma and pooling the cold-insoluble precipitate rich in fibrinogen, factor VIII, von Willebrand factor, and factor XIII. Clinical workflow: the ordering clinician documents an indication (for example, fibrinogen <100 mg/dL with bleeding), the transfusion service verifies crossmatch and product availability, the blood bank issues thawed cryoprecipitate units, bedside nursing performs patient identification and administers the product, and transfusion monitoring and post-transfusion fibrinogen levels are obtained as indicated. Typical sites of service include the inpatient hospital ward, intensive care unit, emergency department, and operating room during perioperative or trauma care. Patient monitoring includes vital signs, signs of transfusion reaction, and laboratory assessment of coagulation parameters after administration.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier	Standard billing when no modifier applies
`22`	Increased procedural services	Rarely used; when substantially greater resources are required for preparing/administering cryoprecipitate beyond usual practice
`23`	Unusual anesthesia	Not typical for transfusion; use only if unusual anesthesia is required for administration
`52`	Reduced services	When fewer units are provided or service is partially reduced compared with usual practice
`53`	Discontinued procedure	If transfusion initiated but discontinued for medical reasons before completion
`55`	Postoperative care only	Not typically applicable; use when only post-op transfusion management is billed separately
`56`	Preoperative management only	Use if only preoperative transfusion preparation is billed separately
`62`	Two surgeons	Not typical for blood product billing; use only in exceptional surgical contexts involving transfusion coordination between two surgeons
`80`	Assistant surgeon	Not applicable to blood product; include only when assistant surgeon billing accompanies a procedure tied to transfusion management
`91`	Repeat clinical diagnostic lab test	When repeat laboratory testing (e.g., fibrinogen level) is performed and billed separately in relation to transfusion

Taxonomy Code	Specialty	Notes
`300010000X`	Hematology	Hematologists frequently order and interpret indications for cryoprecipitate
`207RH0000X`	Emergency Medicine	Emergency physicians commonly order cryoprecipitate in trauma and massive hemorrhage
`208800000X`	Critical Care Medicine	Intensivists manage transfusion in the ICU and coordinate product administration
`207L00000X`	Anesthesiology	Anesthesiologists manage intraoperative transfusion and coagulopathy correction
`340100000X`	Pathology & Laboratory Medicine	Transfusion medicine specialists and blood bank personnel handle product issuance and compatibility testing

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`D65`	Disseminated intravascular coagulation (DIC)	Cryoprecipitate supplies fibrinogen and clotting factors used to correct hypofibrinogenemia in DIC with bleeding
`D67`	Hereditary factor VIII deficiency (Hemophilia A)	Cryoprecipitate contains factor VIII and may be used when factor concentrates are unavailable, though specific factor replacement is preferred
`D68.4`	Acquired coagulation factor deficiency	Used when acquired deficits of fibrinogen or other factors lead to bleeding requiring replacement
`R58`	Hemorrhage, not elsewhere classified	Acute bleeding scenarios where fibrinogen replacement with cryoprecipitate is indicated
`O72.0`	Third-stage postpartum hemorrhage	Obstetric hemorrhage frequently requires cryoprecipitate to restore fibrinogen levels during massive obstetric bleeding
`T80.0`	Hemorrhagic transfusion reaction	Relevant for monitoring and coding transfusion complications related to cryoprecipitate administration
`Z51.11`	Encounter for antineoplastic chemotherapy	Patients receiving chemotherapy may develop coagulopathy or bleeding and require cryoprecipitate during inpatient care
`Z92.83`	Personal history of transfusion reaction	Affects transfusion planning and monitoring when cryoprecipitate is administered

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36430`	Transfusion, blood or blood components, percutaneous, includes all infusions and concurrent monitoring	Used for administration of blood products including cryoprecipitate when billed as a transfusion administration service
`36440`	Transfusion, blood or blood components; each additional unit, peripheral venous catheter	Used when additional units are administered during the same session and may support billing for multiple-unit administration efforts
`36415`	Collection of venous blood by venipuncture	Performed before transfusion for crossmatch, type and screen, and laboratory monitoring
`85610`	Prothrombin time	Coagulation testing often ordered before/after cryoprecipitate to assess bleeding risk and response
`85385`	Fibrinogen; Clauss method	Direct measurement of fibrinogen level used to determine indication for and response to cryoprecipitate transfusion

HCPCS Level II P2029: Congo red blood test

HCPCS-P2028-CEPHALIN-FLOCCULATION-BLOOD

HCPCS P2028: Cephalin Flocculation, Blood

HCPCS-P2031-HAIR-ANALYSIS-EXCLUDING-ARSENIC

HCPCS P2031: Hair Analysis (Excluding Arsenic)

HCPCS-P2033-THYMOL-TURBIDITY-BLOOD-LAB-TEST

HCPCS P2033: Thymol Turbidity, Blood

HCPCS-P2038-MUCOPROTEIN-BLOOD-SEROMUCOID-LAB-TEST

HCPCS P2038: Mucoprotein (Seromucoid) Blood Test

HCPCS-P3000-SCREENING-PAP-SMEAR-TECHNICIAN-SUPERVISED

HCPCS P3000: Screening Papanicolaou Smear by Technician Under Physician Supervision

HCPCS-P3001-SCREENING-PAP-SMEAR-CERVICAL-VAGINAL

HCPCS P3001: Screening Papanicolaou Smear, Cervical or Vaginal

HCPCS-P7001-QUANTITATIVE-URINE-BACTERIAL-CULTURE-SENSITIVITY

HCPCS P7001: Quantitative Bacterial Urine Culture with Sensitivity

HCPCS-P9010-WHOLE-BLOOD-TRANSFUSION-PER-UNIT

HCPCS Level II P9010: Blood (Whole), for Transfusion, Per Unit

HCPCS-P9011-BLOOD-SPLIT-UNIT

HCPCS P9011: Blood, Split Unit

Showing 1–10 of 58

Frequently Asked Questions

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Jul 29, 2026.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier	Standard billing when no modifier applies
`22`	Increased procedural services	Rarely used; when substantially greater resources are required for preparing/administering cryoprecipitate beyond usual practice
`23`	Unusual anesthesia	Not typical for transfusion; use only if unusual anesthesia is required for administration
`52`	Reduced services	When fewer units are provided or service is partially reduced compared with usual practice
`53`	Discontinued procedure	If transfusion initiated but discontinued for medical reasons before completion
`55`	Postoperative care only	Not typically applicable; use when only post-op transfusion management is billed separately
`56`	Preoperative management only	Use if only preoperative transfusion preparation is billed separately
`62`	Two surgeons	Not typical for blood product billing; use only in exceptional surgical contexts involving transfusion coordination between two surgeons
`80`	Assistant surgeon	Not applicable to blood product; include only when assistant surgeon billing accompanies a procedure tied to transfusion management
`91`	Repeat clinical diagnostic lab test	When repeat laboratory testing (e.g., fibrinogen level) is performed and billed separately in relation to transfusion

Taxonomy Code	Specialty	Notes
`300010000X`	Hematology	Hematologists frequently order and interpret indications for cryoprecipitate
`207RH0000X`	Emergency Medicine	Emergency physicians commonly order cryoprecipitate in trauma and massive hemorrhage
`208800000X`	Critical Care Medicine	Intensivists manage transfusion in the ICU and coordinate product administration
`207L00000X`	Anesthesiology	Anesthesiologists manage intraoperative transfusion and coagulopathy correction
`340100000X`	Pathology & Laboratory Medicine	Transfusion medicine specialists and blood bank personnel handle product issuance and compatibility testing

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`D65`	Disseminated intravascular coagulation (DIC)	Cryoprecipitate supplies fibrinogen and clotting factors used to correct hypofibrinogenemia in DIC with bleeding
`D67`	Hereditary factor VIII deficiency (Hemophilia A)	Cryoprecipitate contains factor VIII and may be used when factor concentrates are unavailable, though specific factor replacement is preferred
`D68.4`	Acquired coagulation factor deficiency	Used when acquired deficits of fibrinogen or other factors lead to bleeding requiring replacement
`R58`	Hemorrhage, not elsewhere classified	Acute bleeding scenarios where fibrinogen replacement with cryoprecipitate is indicated
`O72.0`	Third-stage postpartum hemorrhage	Obstetric hemorrhage frequently requires cryoprecipitate to restore fibrinogen levels during massive obstetric bleeding
`T80.0`	Hemorrhagic transfusion reaction	Relevant for monitoring and coding transfusion complications related to cryoprecipitate administration
`Z51.11`	Encounter for antineoplastic chemotherapy	Patients receiving chemotherapy may develop coagulopathy or bleeding and require cryoprecipitate during inpatient care
`Z92.83`	Personal history of transfusion reaction	Affects transfusion planning and monitoring when cryoprecipitate is administered

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36430`	Transfusion, blood or blood components, percutaneous, includes all infusions and concurrent monitoring	Used for administration of blood products including cryoprecipitate when billed as a transfusion administration service
`36440`	Transfusion, blood or blood components; each additional unit, peripheral venous catheter	Used when additional units are administered during the same session and may support billing for multiple-unit administration efforts
`36415`	Collection of venous blood by venipuncture	Performed before transfusion for crossmatch, type and screen, and laboratory monitoring
`85610`	Prothrombin time	Coagulation testing often ordered before/after cryoprecipitate to assess bleeding risk and response
`85385`	Fibrinogen; Clauss method	Direct measurement of fibrinogen level used to determine indication for and response to cryoprecipitate transfusion

HCPCS Level II P2029: Congo red blood test

HCPCS-P2028-CEPHALIN-FLOCCULATION-BLOOD

HCPCS P2028: Cephalin Flocculation, Blood

HCPCS-P2031-HAIR-ANALYSIS-EXCLUDING-ARSENIC

HCPCS P2031: Hair Analysis (Excluding Arsenic)

HCPCS-P2033-THYMOL-TURBIDITY-BLOOD-LAB-TEST

HCPCS P2033: Thymol Turbidity, Blood

HCPCS-P2038-MUCOPROTEIN-BLOOD-SEROMUCOID-LAB-TEST

HCPCS P2038: Mucoprotein (Seromucoid) Blood Test

HCPCS-P3000-SCREENING-PAP-SMEAR-TECHNICIAN-SUPERVISED

HCPCS P3000: Screening Papanicolaou Smear by Technician Under Physician Supervision

HCPCS-P3001-SCREENING-PAP-SMEAR-CERVICAL-VAGINAL

HCPCS P3001: Screening Papanicolaou Smear, Cervical or Vaginal

HCPCS-P7001-QUANTITATIVE-URINE-BACTERIAL-CULTURE-SENSITIVITY

HCPCS P7001: Quantitative Bacterial Urine Culture with Sensitivity

HCPCS-P9010-WHOLE-BLOOD-TRANSFUSION-PER-UNIT

HCPCS Level II P9010: Blood (Whole), for Transfusion, Per Unit

HCPCS-P9011-BLOOD-SPLIT-UNIT

HCPCS P9011: Blood, Split Unit

Showing 1–10 of 58

Frequently Asked Questions

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Jul 29, 2026.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

OpenPayer

HCPCS P9012: Cryoprecipitate, Each Unit

Sign up for hcpcs P9012 policy alerts

Billing Code Overview

Catch payer policy changes before they impact reimbursement

Catch payer policy changes before they impact reimbursement

OpenPayer

HCPCS P9012: Cryoprecipitate, Each Unit

Sign up for hcpcs P9012 policy alerts

Billing Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References

HCPCS P9012: Cryoprecipitate, Each Unit

Sign up for hcpcs P9012 policy alerts

Billing Code Overview

HCPCS P9012: Cryoprecipitate, Each Unit

Sign up for hcpcs P9012 policy alerts

Billing Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

What does HCPCS code P9012 cover and where is it typically used?

How is cryoprecipitate prepared and what is the typical clinical workflow for administration?

Which CPT codes are often billed alongside P9012?

Which modifiers are commonly relevant for billing cryoprecipitate and when might they be used?

What diagnosis codes are typically associated with P9012 claims?

References

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

What does HCPCS code P9012 cover and where is it typically used?

How is cryoprecipitate prepared and what is the typical clinical workflow for administration?

Which CPT codes are often billed alongside P9012?

Which modifiers are commonly relevant for billing cryoprecipitate and when might they be used?

What diagnosis codes are typically associated with P9012 claims?

References